Profilo
Uriel E.
Kusiatin served as President & CEO at NS8 Corp.
in 2008 and later as CEO at Provista Diagnostics, Inc. from 2019 to 2021.
Kusiatin holds an MBA from the University of Pennsylvania.
Precedenti posizioni note di Uriel E. Kusiatin
| Società | Posizione | Fine |
|---|---|---|
Provista Diagnostics, Inc.
 Provista Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provista Diagnostics, Inc. operates as a diagnostic company. It focuses on the development and commercialization of proprietary blood based diagnostic, prognostic, and monitoring tests in women's cancer. Its products include videssa breast, ovarian, endometrial, and HPV associated. The company is headquartered in Alpharetta, GA. | Amministratore Delegato | 01/03/2021 |
| NS8 CORPORATION | Presidente | 22/07/2008 |
Formazione di Uriel E. Kusiatin
| University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NS8 CORPORATION | Commercial Services |
| Aziende private | 1 |
|---|---|
Provista Diagnostics, Inc.
Provista Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provista Diagnostics, Inc. operates as a diagnostic company. It focuses on the development and commercialization of proprietary blood based diagnostic, prognostic, and monitoring tests in women's cancer. Its products include videssa breast, ovarian, endometrial, and HPV associated. The company is headquartered in Alpharetta, GA. | Commercial Services |
- Borsa valori
- Insiders
- Uriel E. Kusiatin
